| Bioactivity | KRAS G12D 8-16 is a mutant KRAS G12D 8-16 peptide[1]. |
| Name | KRAS G12D(8-16) |
| CAS | 199476-92-1 |
| Sequence | Val-Val-Gly-Ala-Asp-Gly-Val-Gly-Lys |
| Shortening | VVGADGVGK |
| Formula | C34H60N10O12 |
| Molar Mass | 800.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang QJ, et al. Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors. Cancer Immunol Res. 2016 Mar;4(3):204-14. |